/Companies

FemTech Startups

807 companies tagged FemTech, with their investors and founders.

Obstetrx

Obstetrx develops a uterine tamponade medical device to control postpartum hemorrhage, adapting hemorrhage-control technology originally created for battlefield trauma. The company is working toward regulatory clearance and commercialization of the device in the US and globally, addressing women's health.

0 investors

Organic Conceptions

Organic Conceptions offers a membership-based program with a personalized education path, a class library, live online events, community interaction, and private coaching aimed at supporting emotional wellness.

0 investors

Project Stardust

Project Stardust develops consumer wearables for continuous fetal monitoring during pregnancy, aiming to detect conditions like fetal growth restriction earlier than periodic prenatal visits. The product targets expectant parents as an alternative to manual kick counting and infrequent ultrasounds.

0 investors

PROMISS Diagnostics

PROMISS Diagnostics develops diagnostic tools that apply analytics to common blood tests to expand their diagnostic capability. The company focuses on affordable, accessible medical diagnostics in the healthcare and life sciences space.

0 investors

Ravgen

Ravgen develops noninvasive prenatal genetic testing, using DNA-based methods to detect fetal genetic conditions such as Down's syndrome from a maternal blood sample. It serves pregnant patients seeking prenatal diagnostic information without the miscarriage risk of invasive procedures.

0 investors

Serenity Medical

Serenity Medical is a medical device company developing the River Stent, an investigational device for treating debilitating venous diseases such as Idiopathic Intracranial Hypertension (IIH) and Pulsatile Tinnitus, conditions that disproportionately affect women.

0 investors

Sermonix Pharmaceuticals

Sermonix Pharmaceuticals is a privately held biotechnology company developing female-specific oncology products, with a lead investigational drug, lasofoxifene, being studied for breast and ovarian cancer. Its ELAINE study evaluates lasofoxifene versus fulvestrant in women with ER+/HER2- metastatic breast cancer carrying an ESR1 mutation.

0 investors

Southeast Alabama Surgical

Southeast Alabama Surgical (SEAS) is an outpatient surgical center offering specialized care for women, including gynecologic surgery, pelvic health, interventional pain procedures, and medical aesthetic services. Based in Dothan, Alabama, it provides physician-led, private outpatient care with planning and aftercare support.

0 investors

Spring Fertility

Spring Fertility operates fertility clinics offering treatments including in vitro fertilization (IVF), IUI, egg freezing, and embryo cryopreservation for individuals and couples building or preserving their fertility. It runs clinics across California, New York, Oregon, and Colorado.

0 investors

TherapeuticsMD

TherapeuticsMD is a royalty company that licenses its women's health products to exclusive licensing partners in the United States and internationally.

0 investors

Vaginal Biome Science

Vaginal Biome Science (VBS) is a biotechnology and R&D company developing microbiome-based diagnostics, therapeutics, and consumer care products for vaginal health, using its patented BioMatch technology and clinical research such as the VENUS Study. It serves the women's health market with clinically validated products and microbiome measurement tools.

0 investors

Vesiflo

Vesiflo manufactures medical devices for urinary retention treatment, specifically targeting women with permanent conditions. The company's primary product, the inFlow Voiding Prosthesis, is designed as a safer alternative to existing bladder drainage solutions.

0 investors

Walela

Walela develops a fetal sensor that provides objective data on a baby's health during labor, helping obstetricians decide whether a C-section is necessary with greater confidence and less liability. The company targets healthcare institutions and clinicians in the prenatal and childbirth monitoring space.

0 investors

Women'S Elite Rugby

Women's Elite Rugby (WER) is the first professional women's rugby league in the United States, launched in 2024 with six founding teams across Boston, Chicago, Denver, New York, Northern California, and the Twin Cities. It organizes elite competition, sells tickets and merchandise, and streams matches live, building on the legacy of the Women's Premier League.

0 investors

YinOva

Yinova Center is an acupuncture and wellness clinic offering acupuncture, Chinese herbal medicine, massage, and fertility support through personalized treatments including consultations, custom herbal formulas, and nutrition plans. It serves patients via in-clinic and virtual appointments, with locations in Manhattan and Brooklyn, New York City.

0 investors

Other sectors & tags